MC38-hPD-L1/hTROP2
Strain Information
*Literature published using this strain should indicate: MC38-hPD-L1/hTROP2 cell line (Cat. NO. NM-S13-TM80) was purchased from Shanghai Model Organisms Center, Inc..
表現型データ
Figure 2. Tumor growth curve of MC38-hPDL1/hTROP2 syngeneic model (n=3).
Figure 3. The expression of hPDL1 and hTROP2 in humanized modified tumors by FACS.
関連の系統
あなたも好きかも
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細
Milestones
Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
詳細